Leah L Zullig1,2, Shelley A Jazowski2,3, Clemontina A Davenport4, Clarissa J Diamantidis2,5, Megan M Oakes2, Sejal Patel5, Jivan Moaddeb5,6, Hayden B Bosworth7,8,9,10,11. 1. Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham Veterans Affairs Health Care System, Durham, NC, USA. 2. Department of Population Health Sciences, Duke University, Durham, NC, USA. 3. Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 4. Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA. 5. Division of General Internal Medicine, Duke University, Durham, NC, USA. 6. Duke Center for Applied Genomics & Precision Medicine, Duke University, Durham, NC, USA. 7. Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham Veterans Affairs Health Care System, Durham, NC, USA. boswo001@duke.edu. 8. Department of Population Health Sciences, Duke University, Durham, NC, USA. boswo001@duke.edu. 9. Division of General Internal Medicine, Duke University, Durham, NC, USA. boswo001@duke.edu. 10. School of Nursing, Duke University, Durham, NC, USA. boswo001@duke.edu. 11. Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA. boswo001@duke.edu.
Abstract
BACKGROUND: Patients with diabetic kidney disease (DKD) often struggle with blood pressure control. In team-based models of care, pharmacists and primary care providers (PCPs) play important roles in supporting patients' blood pressure management. OBJECTIVE: To describe whether PCPs' acceptance of pharmacists' recommendations impacts systolic blood pressure (SBP) at 36 months. DESIGN: An observational analysis of a subset of participants randomized to the intervention arm of the Simultaneous risk factor control using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study. PARTICIPANTS: STOP-DKD participants for whom (1) the pharmacist made at least one recommendation to the PCP; (2) there were available data regarding the PCP's corresponding action; and (3) there were SBP measurements at baseline and 36 months. INTERVENTION: Participants received monthly telephone calls with a pharmacist addressing health behaviors and medication management. Pharmacists made medication-related recommendations to PCPs. MAIN MEASURES: We fit an unadjusted generalized linear mixed model to assess the association between the number of pharmacists' recommendations for DKD and blood pressure management and PCPs' acceptance of such recommendations. We used a linear regression model to evaluate the association between PCP acceptance and SBP at 36 months, adjusted for baseline SBP. KEY RESULTS: Pharmacists made 176 treatment recommendations (among 59 participants), of which 107 (61%) were accepted by PCPs. SBP significantly declined by an average of 10.5 mmHg (p < 0.01) among 47 of 59 participants who had valid measurements at baseline and 36 months. There was a significant association between the number of pharmacist recommendations and the odds of PCP acceptance (OR 1.19; 95%CI 1.00, 1.42; p < 0.05), but no association between the number of accepted recommendations and SBP. CONCLUSIONS: Pharmacists provided actionable medication-related recommendations. We identified a significant decline in SBP at 36 months, but this reduction was not associated with recommendation acceptance. TRIAL REGISTRATION: NCT01829256.
BACKGROUND: Patients with diabetic kidney disease (DKD) often struggle with blood pressure control. In team-based models of care, pharmacists and primary care providers (PCPs) play important roles in supporting patients' blood pressure management. OBJECTIVE: To describe whether PCPs' acceptance of pharmacists' recommendations impacts systolic blood pressure (SBP) at 36 months. DESIGN: An observational analysis of a subset of participants randomized to the intervention arm of the Simultaneous risk factor control using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study. PARTICIPANTS: STOP-DKD participants for whom (1) the pharmacist made at least one recommendation to the PCP; (2) there were available data regarding the PCP's corresponding action; and (3) there were SBP measurements at baseline and 36 months. INTERVENTION: Participants received monthly telephone calls with a pharmacist addressing health behaviors and medication management. Pharmacists made medication-related recommendations to PCPs. MAIN MEASURES: We fit an unadjusted generalized linear mixed model to assess the association between the number of pharmacists' recommendations for DKD and blood pressure management and PCPs' acceptance of such recommendations. We used a linear regression model to evaluate the association between PCP acceptance and SBP at 36 months, adjusted for baseline SBP. KEY RESULTS: Pharmacists made 176 treatment recommendations (among 59 participants), of which 107 (61%) were accepted by PCPs. SBP significantly declined by an average of 10.5 mmHg (p < 0.01) among 47 of 59 participants who had valid measurements at baseline and 36 months. There was a significant association between the number of pharmacist recommendations and the odds of PCP acceptance (OR 1.19; 95%CI 1.00, 1.42; p < 0.05), but no association between the number of accepted recommendations and SBP. CONCLUSIONS: Pharmacists provided actionable medication-related recommendations. We identified a significant decline in SBP at 36 months, but this reduction was not associated with recommendation acceptance. TRIAL REGISTRATION: NCT01829256.
Authors: Ginger A Pape; Jacquelyn S Hunt; Kristina L Butler; Joseph Siemienczuk; Benjamin H LeBlanc; William Gillanders; Yelena Rozenfeld; Kerry Bonin Journal: Arch Intern Med Date: 2011-09-12
Authors: Maryam T Fazel; Alaa Bagalagel; Jeannie K Lee; Jennifer R Martin; Marion K Slack Journal: Ann Pharmacother Date: 2017-06-02 Impact factor: 3.154
Authors: Simone R de Bruin; Nathalie Versnel; Lidwien C Lemmens; Claudia C M Molema; François G Schellevis; Giel Nijpels; Caroline A Baan Journal: Health Policy Date: 2012-08-09 Impact factor: 2.980
Authors: Clarissa J Diamantidis; Hayden B Bosworth; Megan M Oakes; Clemontina A Davenport; Jane F Pendergast; Sejal Patel; Jivan Moaddeb; Huiman X Barnhart; Peter D Merrill; Khaula Baloch; Matthew J Crowley; Uptal D Patel Journal: Contemp Clin Trials Date: 2018-04-10 Impact factor: 2.226
Authors: Sara N Bleich; Cheryl Sherrod; Anne Chiang; Cynthia Boyd; Jennifer Wolff; Eva DuGoff; Eva Chang; Claudia Salzberg; Keely Anderson; Bruce Leff; Gerard Anderson Journal: Prev Chronic Dis Date: 2015-11-12 Impact factor: 2.830